Approvals/NMPA/Beclometasone Dipropionate,Formoterol Fumarate and Glycopyrrolate Inhalation Aerosol

Approved

化学药品

Beclometasone Dipropionate,Formoterol Fumarate and Glycopyrrolate Inhalation Aerosol

CHIESI FARMACEUTICI S.P.A.🇨🇳 National Medical Products Administration

Approval Id: 8FWSEbLOljz
Approval Number: 国药准字HJ20220035
Generic Name: 倍氯福格吸入气雾剂
Generic Name En: Beclometasone Dipropionate,Formoterol Fumarate and Glycopyrrolate Inhalation Aerosol
Drug Type: 化学药品
Dosage Form: 吸入气雾剂
Strength: 每罐120揿，每揿含丙酸倍氯米松100μg、富马酸福莫特罗6μg、格隆溴铵12.5μg （相当于10μg格隆铵）。每揿递送剂量为丙酸倍氯米松87μg、富马酸福莫特罗5μg和格隆溴铵11μg （相当于9μg格隆铵）。
Reg Date: 2022-04-12
Expired Date: 2027-04-11
Company Name: CHIESI FARMACEUTICI S.P.A.
Production Company Name: CHIESI FARMACEUTICI S.P.A.
Company Detail Path: /organization/chiesi-farmaceutici-s-p-a
Production Company Detail Path: /organization/chiesi-farmaceutici-s-p-a

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 12, 2022

Approval ID

8FWSEbLOljz

Type

化学药品